Lerna Bio unveils its first-in-class solution to combat liver failure
- Written by PR Newswire
![]() |
SINGAPORE, CAMBRIDGE, Mass. and SHANGHAI, Nov. 6, 2023 /PRNewswire/ -- Lerna Biopharma Pte. Ltd (Lerna Bio) proudly announces the unveiling of its pioneering liver regeneration drug candidate, LR1, at The Liver Meeting in Boston organized by American Association for the Study of Liver Diseases (AASLD) from November 10th to 14th. During this...
Read more: Lerna Bio unveils its first-in-class solution to combat liver failure















